Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rasmussen's encephalitis: an autoimmune disorder?

P I Andrews1, J O McNamara

  • 1Duke Center for the Advanced Study of Epilepsy, Duke University Medical Center, Durham, North Carolina 27710, USA.

Current Opinion in Neurobiology
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular typing of enteroviruses: comparing 5'UTR, VP1 and whole genome sequencing methods.

Pathology·2022
Same author

The tyrosine receptor kinase B ligand, neurotrophin-4, is not required for either epileptogenesis or tyrosine receptor kinase B activation in the kindling model.

Neuroscience·2006
Same author

Altered regulation of brain-derived neurotrophic factor protein in hippocampus following slice preparation.

Neuroscience·2004
Same author

Survival after pulmonary edema due to enterovirus 71 encephalitis.

Neurology·2003
Same author

Plasmapheresis in Rasmussen's encephalitis. 1996.

Neurology·2002
Same author

Epilepsy and all that jazz.

Nature medicine·2001

Rasmussen's encephalitis, a pediatric epilepsy syndrome, may involve immune system attacks on the glutamate receptor subunit GluR3. This suggests potential autoimmune mechanisms in the disease's progression.

Area of Science:

  • Neuroimmunology
  • Pediatric Neurology
  • Autoimmune Diseases

Background:

  • Rasmussen's encephalitis is a rare, progressive neurological disorder affecting children.
  • Emerging evidence points to the immune system's role in its development.
  • The glutamate receptor subunit GluR3 is implicated as a potential target.

Purpose of the Study:

  • To review the current understanding of Rasmussen's encephalitis pathogenesis.
  • To explore the role of immune mechanisms in the disease.
  • To identify potential autoantigens involved.

Main Methods:

  • Review of experimental animal studies.
  • Analysis of patient data and clinical evidence.
  • Immunological investigation of autoantigens.

Related Experiment Videos

Main Results:

  • Humoral and cell-mediated immunity are likely involved in Rasmussen's encephalitis.
  • The glutamate receptor subunit GluR3 shows potential as a key autoantigen.
  • Evidence supports an autoimmune basis for the syndrome.

Conclusions:

  • Immune responses targeting GluR3 may drive Rasmussen's encephalitis.
  • Further research into autoimmune mechanisms is warranted.
  • Understanding these pathways could lead to new therapeutic strategies.